|
|
||||||||
Ann Thorac Surg 1991;51:262-270
© 1991 The Society of Thoracic Surgeons
Departments of Thoracic and Cardiovascular Surgery, Anesthesiology, and Clinical Chemistry, University Hospital, Uppsala, Sweden
Accepted for publication October 20, 1990.
* Address reprint requests to Dr Svedjeholm, Department of Thoracic and Cardiovascular Surgery, Regionsjukhuset, S-581 85 Linköping, Sweden.
Myocardial insulin resistance, in association with surgical stress, restricts the availability of carbohydrates and increases the load of free fatty acids (FFAs) on the heart. On theoretical grounds adrenergic drugs may be expected to aggravate this situation, whereas the opposite is expected from insulin. The influence of dopamine and a combination of dopamine (7 µg/kg body weight/min) and high-dose insulin (7 IU/kg) on myocardial energy metabolism was studied in 19 patients 4 to 6 hours after a coronary operation. Infusion of dopamine (7 µg/kg body weight/min) induced metabolic changes that may be unfavorable to the strained myocardium. There was an increase of the myocardial FFA load and a rise in myocardial oxygen expenditure by 60% to 70%. These changes were, however, not matched by an increase in myocardial substrate uptake. "Oxygen wastage" of FFA metabolism at high circulating catecholamine levels is suggested. There were also signs suggesting an amplified systemic trauma response: systemic oxygen consumption increased by 15%, and an increase in the arterial levels of FFAs, glucose, and ketones was observed. Divergent metabolic effects of dopamine and insulin were demonstrated. The most prominent metabolic effects of adding high-dose insulin to dopamine were a marked reduction of arterial FFA levels and a shift toward myocardial carbohydrate utilization at the expense of FFAs. Myocardial uptake of FFAs ceased. Myocardial insulin resistance may thus to a significant extent be overcome by supraphysiological doses of insulin, even during infusion of adrenergic drugs.
This article has been cited by other articles:
![]() |
Z. Szabo, R. G. G. Andersson, and H. J. Arnqvist Intraoperative muscle and fat metabolism in diabetic patients during coronary artery bypass grafting surgery: a parallel microdialysis and organ balance study Br. J. Anaesth., August 1, 2009; 103(2): 166 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bothe, M. Olschewski, F. Beyersdorf, and T. Doenst Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis Ann. Thorac. Surg., November 1, 2004; 78(5): 1650 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hynninen, M. A. Borger, V. Rao, R. D. Weisel, G. T. Christakis, J.-A. Carroll, and D. C. H. Cheng The Effect of Insulin Cardioplegia on Atrial Fibrillation After High-Risk Coronary Bypass Surgery: A Double-Blinded, Randomized, Controlled Trial Anesth. Analg., April 1, 2001; 92(4): 810 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tunerir, R. Aslan, S. Isiksoy, O. Colak, Y. Besogul, and T. Kural Benefits of Glucose-Insulin-Potassium Before Mitral Valve Replacement Asian Cardiovasc Thorac Ann, December 1, 1998; 6(4): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. W. Kjellman, K. Bjork, R. Ekroth, H. Karlsson, R. Jagenburg, F. N. Nilsson, G. Svensson, and J. Wernerman Addition of {{alpha}}-Ketoglutarate to Blood Cardioplegia Improves Cardioprotection Ann. Thorac. Surg., June 1, 1997; 63(6): 1625 - 1633. [Abstract] [Full Text] |
||||
![]() |
H. L. Lazar, G. Philippides, C. Fitzgerald, D. Lancaster, R. J. Shemin, and C. Apstein GLUCOSE-INSULIN-POTASSIUM SOLUTIONS ENHANCE RECOVERY AFTER URGENT CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 354 - 362. [Abstract] [Full Text] |
||||
![]() |
T. S. Larsen, O. Irtun, T. K. Steigen, T. V. Andreasen, and D. Sorlie Myocardial Substrate Oxidation During Warm Continuous Blood Cardioplegia Ann. Thorac. Surg., September 1, 1996; 62(3): 762 - 768. [Abstract] [Full Text] |
||||
![]() |
E. Hkanson, R. Svedjeholm, and I. Vanhanen Physiologic aspects in postoperative cardiac patients Ann. Thorac. Surg., February 1, 1995; 59(suppl_1): S12 - S14. [Abstract] [PDF] |
||||
![]() |
R. Svedjeholm, E. Hkanson, and I. Vanhanen Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery Ann. Thorac. Surg., February 1, 1995; 59(suppl_1): S15 - S22. [Abstract] [PDF] |
||||
![]() |
R. Svedjeholm, I. Huljebrant, E. Hkanson, and I. Vanhanen Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations Ann. Thorac. Surg., February 1, 1995; 59(suppl_1): S23 - S30. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |